{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:45:27Z","timestamp":1777895127617,"version":"3.51.4"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00059","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T04:21:42Z","timestamp":1517890902000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Sublingual Administration of Sildenafil Oro-dispersible Film: New Profiles of Drug Tolerability and Pharmacokinetics for PDE5 Inhibitors"],"prefix":"10.3389","volume":"9","author":[{"given":"Luca","family":"De Toni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"De Rocco Ponce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Franceschinis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Dall\u2019Acqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Padrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Realdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Garolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Foresta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/j.1743-6109.2007.00535.x","article-title":"Integrated sildenafil and cognitive-behavior sex therapy for psychogenic erectile dysfunction: a pilot study.","volume":"4","author":"Banner","year":"2007","journal-title":"J. Sex. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1038\/sj.ijir.3901208","article-title":"Potency, selectivity, and consequences of non selectivity of PDE inhibition.","volume":"1","author":"Bischoff","year":"2004","journal-title":"Int. J. Impot. Res. Suppl."},{"key":"B3","first-page":"47","article-title":"Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.","volume":"8","author":"Boolell","year":"1996","journal-title":"Int. J. Impot. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.eururo.2005.01.013","article-title":"Resumption of spontaneous erections in selected patients affected by erectile dysfunction and various degrees of carotid wall alteration: role of tadalafil.","volume":"48","author":"Caretta","year":"2005","journal-title":"Eur. Urol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/j.1743-6109.2008.01112.x","article-title":"Cavernous artery intima-media thickness: a new parameter in the diagnosis of vascular erectile dysfunction.","volume":"6","author":"Caretta","year":"2009","journal-title":"J. Sex. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1111\/j.1743-6109.2012.02787.x","article-title":"Dropout in the treatment of erectile dysfunction with PDE5: a study on predictors and a qualitative analysis of reasons for discontinuation.","volume":"9","author":"Carvalheira","year":"2012","journal-title":"J. Sex. Med."},{"key":"B7","year":"2003","journal-title":"NDA 021400 Levitra (Vardenafil Hydrochloride) Tablets: Clinical Pharmacology\/ Biopharmaceutics Review. Rockville, Md: Department of Health and Human Services"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/andr.12255","article-title":"First-generation phosphodiesterase type 5 inhibitors dropout: a comprehensive review and meta-analysis.","volume":"4","author":"Corona","year":"2016","journal-title":"Andrology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijpharm.2012.03.050","article-title":"A biorelevant in vitro release\/permeation system for oral transmucosal dosage forms.","volume":"430","author":"Delvadia","year":"2012","journal-title":"Int. J. Pharm."},{"key":"B10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1743-6109.2009.01627.x","article-title":"Pharmacotherapy for erectile dysfunction.","volume":"7","author":"Eardley","year":"2010","journal-title":"J. Sex. Med."},{"key":"B11","year":"2016","journal-title":"European Directorate for the Quality of Medicines &HealthCare (EDQM)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jpba.2014.06.010","article-title":"Qualitative and quantitative analysis of PDE-5 inhibitors in counterfeit medicines and dietary supplements by HPLC-UV using sildenafil as a sole reference.","volume":"98","author":"Fej\u0151s","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2174\/187221108786241660","article-title":"Orally disintegrating systems: innovations in formulation and technology.","volume":"2","author":"Goel","year":"2008","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"B14","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1177\/0091270005276847","article-title":"The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction.","volume":"45","author":"Gupta","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.eururo.2010.02.020","article-title":"European Association of Urology. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation.","volume":"57","author":"Hatzimouratidis","year":"2010","journal-title":"Eur. Urol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/cpt.261","article-title":"Pharmacotherapeutic management of erectile dysfunction.","volume":"98","author":"Hawksworth","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2165\/11584950-000000000-00000","article-title":"Pharmacokinetics of a new orodispersible tablet formulation of vardenafil: results of three clinical trials.","volume":"31","author":"Heinig","year":"2011","journal-title":"Clin. Drug Investig."},{"key":"B18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2174\/156720181006131125150249","article-title":"An introduction to fast dissolving oral thin film drug delivery systems: a review.","volume":"10","author":"Kathpalia","year":"2013","journal-title":"Curr. Drug Deliv."},{"key":"B19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.addr.2013.08.011","article-title":"Oral transmucosal drug delivery for pediatric use.","volume":"73","author":"Lam","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/13685538.2013.801952","article-title":"Sildenafil: two decades of benefits or risks?","volume":"16","author":"Leoni","year":"2013","journal-title":"Aging Male"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1093\/humrep\/dew246","article-title":"Semen quality impairment is associated with sexual dysfunction according to its severity.","volume":"31","author":"Lotti","year":"2016","journal-title":"Hum. Reprod."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000354931","article-title":"Organic causes of erectile dysfunction in men under 40.","volume":"92","author":"Ludwig","year":"2014","journal-title":"Urol. Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.pharmthera.2005.07.003","article-title":"Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.","volume":"109","author":"Lugnier","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/sj.ijir.3901522","article-title":"The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy.","volume":"19","author":"Mehrotra","year":"2007","journal-title":"Int. J. Impot. Res."},{"key":"B25","first-page":"69","article-title":"The performance of the Rigiscan in the measurement of penile tumescence and rigidity.","volume":"5","author":"Munoz","year":"1993","journal-title":"Int. J. Impot. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/jsm.12023","article-title":"The ISSM Standards Committee for Sexual Medicine. SOP conservative (medical and mechanical) treatment of erectile dysfunction.","volume":"10","author":"Porst","year":"2013","journal-title":"J. Sex. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.2147\/IJN.S63777","article-title":"Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-\u03b1-tocopheryl polyethylene glycol 1000 succinate nanoemulsions.","volume":"9","author":"Sun","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1111\/j.1464-410X.2008.08328.x","article-title":"Differences in side-effect duration and related bother levels between phosphodiesterase type 5 inhibitors.","volume":"103","author":"Taylor","year":"2009","journal-title":"BJU Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2478\/v10007-012-0027-9","article-title":"An in vitro and in vivo comparative study of directly compressed solid dispersions and freeze dried sildenafil citrate sublingual tablets for management of pulmonary arterial hypertension.","volume":"62","author":"Zayed","year":"2012","journal-title":"Acta Pharm."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00059\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T12:36:47Z","timestamp":1526387807000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00059\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":29,"alternative-id":["10.3389\/fphar.2018.00059"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00059","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,6]]},"article-number":"59"}}